HOME >> BIOLOGY >> NEWS
Progress report on Homogeneous Assay project

International medical diagnostics company Panbio Limited today announced that it has achieved some encouraging results in the development of its Homogeneous Assay Technology.

The company's Advanced Technologies Division has developed a pair of pre-prototype assays for HSV-1 and HSV-2 antibody detection.* The key achievements of this development are:

  • The results obtained were based on real samples whereas, earlier in the project, results were based on a model assay; and
  • The results obtained were consistent with those obtained when using the current ELISA technology.

The company was also pleased that, at this early stage in the project, the results were obtained in less than 50% of the time taken on current ELISA technology.

The development of the assays has also enabled the project team to demonstrate that the design of the antigen used in the assay can have a positive impact on its performance despite the presence of potentially interfering substances in the sera used for testing.

Paul Nitz, Panbio Chief Executive Officer said, "We are pleased with the progress the project team has made. While a number of technical challenges remain, these results increase our confidence of reaching our next goal which is to produce a prototype assay for pre-clinical evaluation by the end of 2006."

Panbio will be presenting a poster at the American Association of Clinical Chemistry (AACC) meeting in Chicago on July 27 outlining the development of the Homogeneous Assay technology to date. The AACC meeting is one of the premier meetings in the world for the medical diagnostics industry. The company will be discussing the progress of the project with a number of potential licensees of the technology.


'"/>

Contact: Dr. Stuart Hazell
61-41-305-1601
Research Australia
21-Jul-2006


Page: 1

Related biology news :

1. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
2. Progress toward a targeted therapy for a specific form of leukemia
3. Progress against sarcoma
4. Progress toward artificial photosynthesis?
5. 2nd annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research awarded to Webster K. Cavenee
6. Progress in battle against life-threatening acute allergy
7. Progress being made in exploring potential use of stem cells to treat heart disease
8. Media Invite: Dinner to award prize for Progress in Cancer Research
9. Progress needed on global regime for access to genetic resources and benefit-sharing
10. Albert Szent-Gyrgyi Prize for Progress in Cancer Research announced
11. Progress toward a new remedy for chronic urinary tract infections?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... September 21, 2018 , ... ... if left untreated, can lead to significant morbidity and mortality. VTE affects between ... diagnosed upon autopsy. Further, PE is the leading cause of preventable hospital death ...
(Date:9/12/2018)... ... September 11, 2018 , ... ... to introduce the new ChemXP™ line of high performance secondary containment coatings, designed ... developed to provide Tennant Coatings’ elite certified installers with the needed solutions to ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... and sister to show Sensors Expo & Conference , announces their partnership ... CA to conduct an IoT Enabled Industrial IoT Certification Program. Taking place on ...
Breaking Biology News(10 mins):
(Date:8/23/2018)... ... 22, 2018 , ... Crucial Data Solutions, Inc. announces the ... first fully-featured app for electronic data capture (EDC) and electronic participant reported outcomes ... percent of the market share for mobile devices worldwide; in turn, this enables ...
(Date:8/21/2018)... ... 21, 2018 , ... The Connecticut Technology Council (CTC) and Marcum LLP today ... technology companies in Connecticut. This year’s group of top-ranked companies will be honored at ... Connecticut Convention Center in Hartford. A complete list of the Marcum Tech Top 40 ...
(Date:8/17/2018)... Calif. (PRWEB) , ... August 16, 2018 , ... ... genetic testing, announced their results from the AmbryShare project were published today in ... genes in the largest exome study ever conducted. , Every year hereditary breast ...
(Date:8/14/2018)... ... August 14, 2018 , ... Buprenorphine (BUP) ... disorder. BUP is often prescribed as a sublingual co-formulation with the opioid antagonist ... webinar, participants will learn from a review of the pharmacokinetics of BUP, NBP, ...
Breaking Biology Technology:
Cached News: